文献速递造血干细胞移植与细胞治疗

组织浸润的同种反应性T细胞需要Id3来规避PD-1介导的免疫抑制从而维持移植物抗宿主病

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.
PubMed 文献 · Blood · 2024-01-01

该研究在小鼠中发现,DNA结合抑制因子Id3对维持肝脏和肠道等GVHD靶组织中T细胞反应至关重要;Id3缺失导致多能Th1细胞异常表达PD-1、组织浸润PD-1+多能Th1细胞数量减少、肝脏TCF-1+祖样T细胞维持受损并抑制GVHD,而PD-1阻断可恢复Id3缺失供者T细胞介导GVHD的能力。

要点

  • Id3缺失使多能Th1细胞异常表达PD-1,减少组织浸润PD-1+多能Th1细胞并抑制GVHD。
  • PD-1阻断可恢复Id3缺失供者T细胞介导GVHD的能力。
  • 供者T细胞Id3缺失保留了小鼠同种异体造血干细胞移植中的移植物抗肿瘤效应。

核心结论

  • Id3是减轻GVHD的重要靶点,其基因编辑方案可能在T细胞免疫治疗中有广泛意义。

研究设计与样本

  • 小鼠GVHD模型研究,结合单细胞RNA测序、全基因组RNA测序及CRISPR/Cas9基因编辑。
  • 在人CD19靶向嵌合抗原受体T细胞中行CRISPR/Cas9敲除ID3,并在NOD/SCID/IL2Rg-/-小鼠中评估。

主要发现

  • Id3缺失导致多能Th1细胞异常表达PD-1、组织浸润PD-1+多能Th1细胞数量减少、肝脏TCF-1+祖样T细胞维持受损并抑制GVHD。
  • PD-1阻断恢复Id3缺失供者T细胞介导GVHD的能力。
  • 单细胞RNA测序显示Id3缺失使组织浸润多能Th1细胞中CD28和PI3K/AKT信号活性显著降低。
  • Id3通过限制Nfatc2、Fos、Jun、Ets1和Prdm1等转录因子的染色质可及性来抑制其转录。
  • 供者T细胞Id3缺失在小鼠同种异体造血干细胞移植中保留了移植物抗肿瘤效应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Persisting alloreactive donor T cells in target tissues are a determinant of graft-versus-host disease (GVHD), but the transcriptional regulators that control the persistence and function of tissue-infiltrating T cells remain elusive. We demonstrate here that Id3, a DNA-binding inhibitor, is critical for sustaining T-cell responses in GVHD target tissues in mice, including the liver and intestine. Id3 loss results in aberrantly expressed PD-1 in polyfunctional T helper 1 (Th1) cells, decreased tissue-infiltrating PD-1+ polyfunctional Th1 cell numbers, impaired maintenance of liver TCF-1+ progenitor-like T cells, and inhibition of GVHD. PD-1 blockade restores the capacity of Id3-ablated donor T cells to mediate GVHD. Single-cell RNA-sequencing analysis revealed that Id3 loss leads to significantly decreased CD28- and PI3K/AKT-signaling activity in tissue-infiltrating polyfunctional Th1 cells, an indicator of active PD-1/PD-L1 effects. Id3 is also required for protecting CD8+ T cells from the PD-1 pathway-mediated suppression during GVHD. Genome-wide RNA-sequencing analysis reveals that Id3 represses transcription factors (e.g., Nfatc2, Fos, Jun, Ets1, and Prdm1) that are critical for PD-1 transcription, exuberant effector differentiation, and interferon responses and dysfunction of activated T cells. Id3 achieves these effects by restraining the chromatin accessibility for these transcription factors. Id3 ablation in donor T cells preserved their graft vs tumor effects in mice undergoing allogeneic hematopoietic stem cell transplantation. Furthermore, CRISPR/Cas9 knockout of ID3 in human CD19-directed chimeric antigen receptor T cells retained their antitumor activity in NOD/SCID/IL2Rg-/- mice early after administration. These findings identify that ID3 is an important target to reduce GVHD, and the gene-editing program of ID3 may have broad implications in T-cell-based immunotherapy.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Wang Y, He S, Calendo G, et al. Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD. Blood. 2024. PMID: 37871574. doi:10.1182/blood.2023021126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。